Nominations for the 2009 Award will open in September 2008.
Nomination deadline: Wednesday, October 15, 2008 at 4:00 p.m., U.S. Eastern Time.
Learn more about the 2008 Award winner Dr. Joseph R. Bertino. View the list of all past winners.
The Award & Lecture
This Award was established in 1996 to recognize outstanding achievements in clinical cancer research. It is named for the late Dr. Joseph H. Burchenal, Honorary Member and Past President of the AACR, and a major figure in clinical cancer research and chemotherapy.
The winner of the 14th Annual AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research will give a 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009), and receive an honorarium of $10,000 and support for attendance at the meeting.
Eligibility
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
- The Award will be presented to an individual investigator.
- Institutions or organizations are not eligible for the Award.
Nomination Process
Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves.
Nomination letters must be sent electronically to the AACR to awards@aacr.org no later than 4:00 p.m. United States Eastern Time on Thursday, October 30, 2008. Preferred file formats are *.doc, *.pdf. Paper nominations will not be accepted. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.
The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:
- the name of the AACR Award for which the candidate is being nominated;
- a brief statement of no more than 50-words summarizing the candidate's outstanding achievements in clinical cancer research;
- a concise description of the candidate's outstanding achievements in clinical cancer research; publications supporting these contributions may be directly referenced within the letter; and
- a concise description of the impact of these contributions on the field.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.
Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's achievements in clinical cancer research. No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.
Supporter
Generously supported by Bristol-Myers Squibb.
Questions?
Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404